• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by FOXO Technologies Inc.

    8/14/25 4:05:17 PM ET
    $FOXO
    Life Insurance
    Finance
    Get the next $FOXO alert in real time by email
    NT 10-Q 1 formnt10-q.htm NT 10-Q

     

     

     

    U.S. SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON D.C. 20549

     

    FORM 12b-25

    Commission File Number 001-39783

     

    NOTIFICATION OF LATE FILING

     

    (Check One):

    ☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR

     

    For Period Ended: June 30, 2025    
         
    ☐ Transition Report on Form 10-K   ☐ Transition Report on Form 10-Q
    ☐ Transition Report on Form 20-F   ☐ Transition Report on Form N-SAR
    ☐ Transition Report on Form 11-K    

     

    For the Transition Period Ended:

     

    Read Attached Instruction Sheet Before Preparing Form. Please Print or Type.

     

    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     

    Part I-Registrant Information

     

    Full Name of Registrant   FOXO Technologies Inc.
         
    Former Name if Applicable   Delwinds Insurance Acquisition Corp.
         
    Address of principal executive office   477 South Rosemary Avenue, Suite 224
         
    City, State and Zip Code   West Palm Beach, FL 33401

     

     

     

     

     

     

    Part II-Rules 12b-25 (b) and (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate) ☒

     

      a. The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
         
      b. The subject annual report, semi-annual report, transition report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
         
      c. The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    Part III-Narrative

     

    State below in reasonable detail the reasons why the form 10-K, 11-K, 20-F, 10-Q or N-SAR, or the transition report or portion thereof could not be filed within the prescribed time period. (Attach extra sheets of needed.)

     

    The Company is unable to file, without unreasonable effort and expense, its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 within the prescribed time period because the Company is still completing the Form 10-Q and its auditors have not completed their review of the financial statements for the period then ended. The Company expects to file its Form 10-Q on or prior to the fifth calendar day following the prescribed due date.

     

    Part IV-Other Information

     

      1. Name and telephone number of person to contact in regard to this notification

     

      Seamus Lagan   (612)   800-0059
      (Name)   (Area Code)   (Telephone No.)

     

      2. Have all other periodic reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).

     

    ☒ Yes ☐ No

     

      3. Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

     

    ☐ Yes ☒ No

     

    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

    2

     

     

    FOXO Technologies Inc.

    (Name of Registrant as specified in charter)

     

    has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

     

    Date: August 14, 2025 By /s/ Seamus Lagan
        Seamus Lagan, Chief Executive Officer

     

    3

    Get the next $FOXO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FOXO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FOXO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FOXO TECHNOLOGIES INC. ANNOUNCES THAT ITS COMMON STOCK CAN BE QUOTED AND TRADED ON THE OVER THE COUNTER MARKET FROM AUGUST 13, 2025.

    WEST PALM BEACH, FLORIDA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. ("FOXO" or the "Company") announces that it has received a letter from NYSE on August 12, 2025 confirming that NYSE Regulation has determined to commence proceedings to delist the Class A common stock of FOXO (Ticker symbol FOXO) from NYSE American, pursuant to Section 1003(f)(v) of the NYSE American Company Guide due to the low selling price of the Class A commons stock. The share price went below the NYSE minimum price of $0.10 on August 12, 2025 and was immediately suspended from trading by NYSE. The Company submitted an application to have its common stock traded on the OTC and has on August 12, 2025 re

    8/13/25 7:52:00 AM ET
    $FOXO
    Life Insurance
    Finance

    FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON-BINDING ACQUISITION AGREEMENT FOR AN ASSISTED-LIVING FACILITY IN SOUTH FLORIDA FOR A TOTAL CONSIDERATION OF $22 MILLION

    WEST PALM BEACH, FLORIDA, Aug. 06, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company") announces that it has executed a non-binding acquisition agreement to acquire an assisted living and memory care facility in South Florida. The proposed acquisition includes the land and buildings. The facility has 87 units licensed for the provision of assisted living and memory care services. The purchase price for the facility is expected to be $22 million, a portion of which is milestone-based. $5M of the purchase price will be in the form of non-convertible preferred stock. Completion of the acquisition is subject to definitive agreements and a number of closing co

    8/6/25 7:43:00 AM ET
    $FOXO
    Life Insurance
    Finance

    FOXO TECHNOLOGIES INC.'S BIG SOUTH FORK MEDICAL CENTER COMPLETES PERFORMANCE NETWORK AGREEMENT WITH COVENANT HEALTH TO PROVIDE SWING BED SERVICES

    WEST PALM BEACH, FLORIDA, Aug. 01, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company") today announced that its critical access designated rural hospital, Big South Fork Medical Center located in Oneida, Tennessee, has completed a Performance Network Agreement with Covenant Health to join their performance network as a provider of swing bed services. Covenant Health is a large, muti-facility hospital network serving greater Knoxville and East Tennessee. Patients who no longer meet acute care admission criteria are frequently in need of post-acute care to enhance their recovery. Big South Fork Medical Center is well positioned to provide swing bed services

    8/1/25 7:52:00 AM ET
    $FOXO
    Life Insurance
    Finance

    $FOXO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Langley Trevor claimed ownership of 1,023,629 shares (SEC Form 3)

    3 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)

    9/12/24 5:28:21 PM ET
    $FOXO
    Life Insurance
    Finance

    New insider Lagan Seamus claimed ownership of 1,023,629 shares (SEC Form 3)

    3 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)

    9/12/24 5:27:29 PM ET
    $FOXO
    Life Insurance
    Finance

    Large owner Kr8 Ai Inc. sold $325,000 worth of shares (1,300,000 units at $0.25), closing all direct ownership in the company (SEC Form 4)

    4 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)

    7/24/24 4:00:23 PM ET
    $FOXO
    Life Insurance
    Finance

    $FOXO
    SEC Filings

    View All

    SEC Form 25-NSE filed by FOXO Technologies Inc.

    25-NSE - FOXO TECHNOLOGIES INC. (0001812360) (Subject)

    8/22/25 11:27:59 AM ET
    $FOXO
    Life Insurance
    Finance

    SEC Form 10-Q filed by FOXO Technologies Inc.

    10-Q - FOXO TECHNOLOGIES INC. (0001812360) (Filer)

    8/19/25 4:01:13 PM ET
    $FOXO
    Life Insurance
    Finance

    Amendment: SEC Form 10-Q/A filed by FOXO Technologies Inc.

    10-Q/A - FOXO TECHNOLOGIES INC. (0001812360) (Filer)

    8/19/25 10:52:54 AM ET
    $FOXO
    Life Insurance
    Finance

    $FOXO
    Leadership Updates

    Live Leadership Updates

    View All

    FOXO TECHNOLOGIES INC.'S BIG SOUTH FORK MEDICAL CENTER COMPLETES PERFORMANCE NETWORK AGREEMENT WITH COVENANT HEALTH TO PROVIDE SWING BED SERVICES

    WEST PALM BEACH, FLORIDA, Aug. 01, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company") today announced that its critical access designated rural hospital, Big South Fork Medical Center located in Oneida, Tennessee, has completed a Performance Network Agreement with Covenant Health to join their performance network as a provider of swing bed services. Covenant Health is a large, muti-facility hospital network serving greater Knoxville and East Tennessee. Patients who no longer meet acute care admission criteria are frequently in need of post-acute care to enhance their recovery. Big South Fork Medical Center is well positioned to provide swing bed services

    8/1/25 7:52:00 AM ET
    $FOXO
    Life Insurance
    Finance

    FOXO TECHNOLOGIES INC. CREATES ACQUISITION VEHICLE AND APPOINTS NEW INTERIM CFO

    WEST PALM BEACH, FLORIDA, June 16, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company") today announced that it formed a new, wholly-owned subsidiary intended to be used to acquire identified acquisition targets in the healthcare services and related sectors. On June 13, 2025, the Company formed FOXO Acquisition Corporation, a Florida corporation, for the purpose of acquiring targeted acquisitions. The Company also intends to create a new series of non-convertible preferred stock with a goal to have this preferred stock publicly listed (with its own trading symbol) and use it to as a mechanism to complete such acquisitions. The new series of preferred stoc

    6/16/25 7:43:00 AM ET
    $FOXO
    Life Insurance
    Finance

    FOXO TECHNOLOGIES INC. ANNOUNCES RESTRUCTURING AND CAPITAL RAISING TRANSACTIONS AND APPOINTS SEAMUS LAGAN AS CHIEF EXECUTIVE OFFICER

    MINNEAPOLIS, MN, Dec. 11, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the "Company" or "FOXO") announces a series of restructuring and capital raising transactions which will improve the Company's balance sheet, satisfy minimum stockholders' equity requirements of the NYSE American and provide capital for growth and reduce outstanding liabilities. The Company also announces a change in senior leadership. Key transactions include: Rennova Health, Inc.'s exchange of approximately $21 million of a Senior Secured Note issued by Rennova Community Health, Inc., the Company's subsidiary, into 21,000 shares of the Company's Series A Cumulative Convertible Redeemable Pr

    12/11/24 8:00:00 AM ET
    $FOXO
    Life Insurance
    Finance

    $FOXO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by FOXO Technologies Inc.

    SC 13G/A - FOXO TECHNOLOGIES INC. (0001812360) (Subject)

    11/7/24 8:46:01 AM ET
    $FOXO
    Life Insurance
    Finance

    Amendment: SEC Form SC 13D/A filed by FOXO Technologies Inc.

    SC 13D/A - FOXO TECHNOLOGIES INC. (0001812360) (Subject)

    9/23/24 4:15:07 PM ET
    $FOXO
    Life Insurance
    Finance

    SEC Form SC 13D filed by FOXO Technologies Inc.

    SC 13D - FOXO TECHNOLOGIES INC. (0001812360) (Subject)

    8/5/24 4:15:29 PM ET
    $FOXO
    Life Insurance
    Finance

    $FOXO
    Financials

    Live finance-specific insights

    View All

    FOXO TECHNOLOGIES INC. DESIGNATES NEW SERIES OF PREFERRED STOCK TO BE USED FOR ACQUISITIONS

    WEST PALM BEACH, FLORIDA, June 27, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company") today announced that it has designated a new series of its preferred stock (Series E Cumulative Redeemable Secured Preferred Stock e (the "Series E Preferred Stock")) and filed the series' certificate of designation with the Secretary of State of Delaware. The newly designated series of preferred stock includes: (i) a stated value of $25.00 per share, (ii) a 2.5% per annum cash dividend paid semi-annually, (iii) a 5.0% per annum common stock dividend paid semi-annually, and (iv) a security interest in the stock of the Company's recently formed acquisition vehicle, FOXO A

    6/27/25 7:27:00 AM ET
    $FOXO
    Life Insurance
    Finance

    FOXO TECHNOLOGIES, INC., PROVIDES UPDATE ON RECENT ACOMPLISHMENTS AND BUSINESS STRATEGY

    MINNEAPOLIS, MN, Jan. 28, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the "Company"), provides a brief shareholder letter from Seamus Lagan, recently appointed CEO of FOXO on what has been achieved in recent months and what is planned for 2025 and beyond. Dear Fellow Shareholders, Our recent shareholders meeting on January 17th concluded the requirements of 2024 acquisition agreements and resulted in a change of control of the Company. The accomplishments in the second half of 2024 have been key to what we believe is becoming a very successful turnaround of our Company and has created a foundation from which we believe we can build a significant and profitable

    1/28/25 8:05:00 AM ET
    $FOXO
    Life Insurance
    Finance

    FOXO TECHNOLOGIES INC., PROVIDES UPDATE ON 2024 ACCOMPLISHMENTS AND PLANS FOR REMAINDER OF THE YEAR

    MINNEAPOLIS, MN, Oct. 15, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the "Company" or "FOXO"), provides a shareholder letter from Mark White, Interim CEO of FOXO, on what has been achieved in 2024 and what is planned for the remainder of 2024 and beyond. Dear Fellow Shareholders, 2024 has been an exciting, tumultuous and productive year for us. We believe the accomplishments already completed and that we believe will be achieved before year-end create a foundation from which we can build a successful enterprise that will increase shareholder value. The Company began 2024 with a continued focus on commercializing its epigenetic technology while, at the same ti

    10/15/24 8:30:00 AM ET
    $FOXO
    Life Insurance
    Finance